Washington, D.C. June 4th Prostate Cancer Walk

02 June 2007 Filed under Awareness Events, Prostate Cancer Posted by » No Comments

Washington DC walk & assembly

When: Monday, June 4th

Purpose:

To display our unified dissatisfaction with recent FDA Provenge ruling, and gain news coverage as the largest D.C. prostate cancer assembly ever held (350 or more). We are raising a voice for prostate cancer once again, and the unmet need for more treatment options for advanced PC patients. We are building on what we accomplished together at the March 29th FDA Provenge review meeting.

We ARE newsworthy! (ABC, NBC, CNBC, Seattle Times, and Wall St Journal so far)

We ARE a powerful voice and force!

We ARE a larger group of voting taxpayers than the government seems to realize.

We WANT better communication and representation!

How can an organization claim to be objective when they’ve totally lost sight of the object? We ARE the object.

Attire: Blue shirt, any type
Blue jeans, jean shorts, or jean skirt (or something comparable).
Those who have a military or law enforcement job, wear your uniform if you can.
Those in the medical field, wear your uniform if you like.
(we will have blue rain ponchos in case of inclement weather for $1 donation)
Wear comfortable shoes.
Bring water.

Signs: Inquire with Jan on content. There are strict regulations for signs, but signmakers are welcome. Again, you must inquire with Jan at (239) 395-0995 or [email protected]

Visual Ideas:
Bring men & women in uniform.
Bring a friend, family member.
We are working on having music.
We are working on trucks with blue ribbon, etc.
Motorcycles canNOT find a place to park, so not a workable idea.

This is being organized by Jan Manarite of PCRI, and Raise A Voice. Jan helped to organize and coordinate the success at the March 29th FDA Provenge review meeting. Our plan is to make this another memorable, meaningful event for men with prostate cancer.Washington DC walk & assembly

Tags: ,

Trackback URL

No Comments

You must be logged in to post a comment.